Nu-Med Plus (NUMD) EPS (Diluted) Growth (3y) (2018 - 2025)
Nu-Med Plus (NUMD) EPS (Diluted) Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 18.07% |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | 40.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.68% |
| Sep 30, 2025 | 41.84% |
| Jun 30, 2025 | 42.43% |
| Mar 31, 2025 | 31.79% |
| Dec 31, 2024 | 83.81% |
| Sep 30, 2024 | 46.41% |
| Jun 30, 2024 | 58.88% |
| Mar 31, 2024 | 65.82% |
| Dec 31, 2023 | 57.94% |
| Sep 30, 2023 | 72.75% |
| Jun 30, 2023 | 75.34% |
| Mar 31, 2023 | 53.13% |
| Dec 31, 2022 | 28.34% |
| Sep 30, 2022 | 41.32% |
| Jun 30, 2022 | 50.24% |
| Mar 31, 2022 | 58.14% |
| Dec 31, 2021 | -52.10% |
| Sep 30, 2021 | 51.71% |
| Jun 30, 2021 | 10.98% |
| Mar 31, 2021 | -21.35% |